ALEXANDRIA, Va., July 9 -- United States Patent no. 12,352,752, issued on July 8, was assigned to ACADEMY OF MILITARY MEDICAL SCIENCES (Beijing) and BEIJING PROTEOME RESEARCH CENTER (Beijing).

"Application of Niemann-Pick C1 protein in diagnosis and treatment of cancer" was invented by Ying Jiang (Beijing), Aihua Sun (Beijing), Fuchu He (Beijing), Chaoying Li (Beijing), Jinan Zhou (Beijing) and Handong Wei (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A use of Niemann-Pick C1 (NPC1) protein and a substance that inhibits NPC1 gene expression and/or protein activity, which is selected from at least one of the following (a)-(h): (a) for the preparation of kits for diagnosing cancer; (b) for the prepar...